Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ludesi is a bioinformatics company specializing in advanced image analysis for proteomics, specifically focusing on two-dimensional gel electrophoresis (2DE). The company developed proprietary software and a service-based platform designed to provide highly accurate and reproducible protein discovery data by eliminating the manual bottlenecks and errors associated with traditional gel analysis. Their flagship technology, Ludesi RED, offered a standardized approach to image processing, enabling researchers in drug discovery and clinical diagnostics to identify biomarkers more efficiently. By providing both software-as-a-service (SaaS) and expert analysis services, Ludesi became a key partner for academic and pharmaceutical laboratories worldwide. The company was eventually acquired, integrating its specialized proteomics capabilities into a broader life sciences portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ludesi.